Stage III Prostate Cancer AJCC v8
Oncology·MeSH: Prostatic Neoplasms
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
0 drugs in development·0 companies·10 clinical trials
Frequently asked questions
How many clinical trials target Stage III Prostate Cancer AJCC v8?
There are 10 clinical trials targeting Stage III Prostate Cancer AJCC v8 tracked by BioSniper.
What is the prevalence of Stage III Prostate Cancer AJCC v8?
The estimated prevalence of Stage III Prostate Cancer AJCC v8 is approximately 256.0 per 100,000 population.
Deep-dive into Stage III Prostate Cancer AJCC v8
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis